Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<ns4:p><ns4:bold>Background: </ns4:bold>Neuropathic pain is an increasingly prevalent condition and has a major impact on health and quality of life. However, the risk factors for the development and maintenance of neuropathic pain are poorly understood. Clinical, genetic and psychosocial factors all contribute to chronic pain, but their interactions have not been studied in large cohorts. The DOLORisk study aims to study these factors.</ns4:p><ns4:p> <ns4:bold>Protocol: </ns4:bold>Multicentre cross-sectional and longitudinal cohorts covering the main causes leading to neuropathic pain (e.g. diabetes, surgery, chemotherapy, traumatic injury), as well as rare conditions, follow a common protocol for phenotyping of the participants. This core protocol correlates answers given by the participants on a set of questionnaires with the results of their genetic analyses. A smaller number of participants undergo deeper phenotyping procedures, including neurological examination, nerve conduction studies, threshold tracking, quantitative sensory testing, conditioned pain modulation and electroencephalography.</ns4:p><ns4:p> <ns4:bold>Ethics and dissemination: </ns4:bold>All studies have been approved by their regional ethics committees as required by national law. Results are disseminated through the <ns4:ext-link xmlns:ns3="" ext-link-type="uri" ns3:href="">DOLORisk website</ns4:ext-link>, scientific meetings, open-access publications, and in partnership with patient organisations.</ns4:p><ns4:p> <ns4:bold>Strengths and limitations:</ns4:bold> <ns4:list list-type="bullet"><ns4:list-item><ns4:p>Large cohorts covering many possible triggers for neuropathic pain</ns4:p></ns4:list-item><ns4:list-item><ns4:p>Multi-disciplinary approach to study the interaction of clinical, psychosocial and genetic risk factors</ns4:p></ns4:list-item><ns4:list-item><ns4:p>High comparability of the data across centres thanks to harmonised protocols</ns4:p></ns4:list-item><ns4:list-item><ns4:p>One limitation is that the length of the questionnaires might reduce the response rate and quality of responses of participants</ns4:p></ns4:list-item></ns4:list></ns4:p>

Original publication




Journal article


Wellcome Open Research


F1000 Research Ltd

Publication Date





63 - 63